Cita APA

Kalac, M., Scotto, L., Marchi, E., Amengual, J., Seshan, V. E., Bhagat, G., . . . O'Connor, O. A. (2011). HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL. American Society of Hematology.

Chicago Style Citation

Kalac, Matko, et al. HDAC Inhibitors and Decitabine Are Highly Synergistic and Associated With Unique Gene-expression and Epigenetic Profiles in Models of DLBCL. American Society of Hematology, 2011.

Cita MLA

Kalac, Matko, et al. HDAC Inhibitors and Decitabine Are Highly Synergistic and Associated With Unique Gene-expression and Epigenetic Profiles in Models of DLBCL. American Society of Hematology, 2011.